Results
NHS-DPPD practices prescribed an average of 576.1 antibiotics per 1000 patients per year (329.9 at the 5th percentile and 808.7 at the 95th percentile). The levels of prescribing of antibiotics and other medicines were strongly correlated. Practices with high levels of prescribing of other medicines (a rate of 27 159.8 at the 95th percentile) prescribed 80% more antibiotics than low-prescribing practices (rate of 8815.9 at the 5th percentile). After adjustment, NHS-DPPD practices with high prescribing of other medicines gave 60% more antibiotic prescriptions than lowprescribing practices (corresponding to higher prescribing of 276.3 antibiotics per 1000 patients per year). Prescribing of non-opioid painkillers and benzodiazepines were also strong indicators of the level of antibiotic prescribing. General prescribing levels were a much stronger driver for antibiotic prescribing than other risk factors, such as deprivation.
Conclusion
The propensity of GPs to prescribe medications generally is an important driver for antibiotic prescribing. Interventions that aim to optimise antibiotic prescribing will need to target general prescribing behaviours, in addition to specifically targeting antibiotics.
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number of registered patients (list size). The authors' analyses were based on the NHS-DPPD data from 2015. 10 Medication groups were analysed based on the British National Formulary (BNF). NHS-DPPD was linked using the practice postcode or practice ID to the Index of Multiple Deprivation (IMD), 11 patient survey data of experiences of their practice, 12 Quality and Outcomes Framework (QOF) data for chronic obstructive pulmonary disease (COPD) and asthma, 9 and GP workforce data. 13 The QOF is a national incentive programme that provides financial rewards to GP practices in England for the quality of care.
14 CPRD contains anonymised patient-level electronic health records (EHRs) of a broadly representative sample of general practices in the UK, and includes >10 million patients. 9 The data recorded in the CPRD include patient demographic information, prescriptions supplied (including BNF category), diagnoses, test results, and specialist referrals. The postcodes of CPRD practices were not available to researchers (for reasons of data confidentiality). CPRD data for 2014 were used, as this was the most recent calendar year available to the authors.
General practices with outlier values were excluded from the analyses. Specifically, practices with a small list size (≤750), few number of patients per GP full-time equivalent (≤500), and practices that were below the 1st and above the 99th percentile for the rate of antibiotic prescriptions 15 were excluded. Practices with a small number of patients per GP full-time equivalent were retained for CPRD as this dataset did not have the GP full-time equivalent variable. Practices that had missing values in one of the covariates were also excluded (the percentage of missing records was small, ranging from 0.5% to 1.3%).
The variables of interests included the rate of antibiotic prescribing and that of other (non-antibiotic) medicines. The authors further explored the associations with non-opioid analgesics and benzodiazepine prescribing, as longstanding guidance has also advocated judicious use of these medicines. The rates were the sum of prescriptions in each practice divided by list size. The selection of medicines was based on the BNF classification (systemic antibiotics BNF categories 5.1.1 to 5.1.8, and 5.1.11 to 5.1.13), other medicines (1-14 excluding 1.8, 11.9 and 13.11, 13.12 and 13.13, and systemic antibiotics), non-opioid analgesics (4.7.1 to 4.7.5), and benzodiazepines (4.1.1 and 4.1.2). Prescriptions for bandages or devices were excluded.
Potential confounders between the rates of antibiotic prescribing and risk factors in the NHS-DPPD analyses were deprivation scores in the following domains: employment; health; crime; income deprivation affecting older people, children, and young people's education; adult skills; wider barriers; indoor environments; outdoor environments; practice characteristics (such as patient's age, or QOF achievements); and patient survey results of satisfaction with their practice. Postcodes were used to define the regional location of the practices. 16 Potential confounders in the CPRD analyses included distribution of Charlson comorbidity index, 17 smoking and body mass index, rates of patients consulting their practice for upper respiratory tract infections, lower respiratory tract infection, or urinary tract
How this fits in
Current interventions that focus specifically on improving the treatment or understanding of common infections have had limited effectiveness in reducing antibiotic prescribing in primary care. The propensity of GPs to prescribe medications is an important driver for antibiotic prescribing. Interventions that aim to optimise antibiotic prescribing will need to consider the general prescribing behaviour in primary care. infection, lung or skin infection, ethnicity, and region of practice. Linear regression measured the association between rates of antibiotics prescribing (dependent variable) and risk factors (independent variable), such as rate of prescribing of other medicines. The interquartile range (IQR) and 5th and 95th percentiles were measured in the distribution of each risk factor. The authors quantified the change in the rate of antibiotic prescribing by multiplying risk factors' coefficients (beta) from linear models to corresponding risk factors' IQR (or range of 5th percentile to 95th percentile). This common approach is similar to standardised coefficients, as both of them are a way to present models' coefficients (betas) of all risk factors in the same scale, so the coefficients of all risk factors can be fairly compared with each other. The list size of practices was used as a weight. Standard techniques were used to reduce the number of potential confounders in the adjusted models (including exclusion of variables of Pearson correlation coefficients of >0.6, those that influenced the variance inflation factor ≥10 reflecting severe collinearity between variables, and backward regression using Akaike information criterion). Residual, normal Q-Q, standardised residual, and Cook's distance plots were used to check the statistical assumptions of the regression models. Poisson models were also fitted to check whether their results were consistent with the linear regression models. Pearson coefficients between rates of antibiotic prescribing and those of other medicines, painkillers, and benzodiazepines were calculated.
An explorative analysis evaluated the association between the rate of antibiotic prescribing and that of other specific classes of medicines. These classes included all BNF categories for medicines (excluding non-opioid analgesics and benzodiazepines) prescribed to at least 1% of the study population. The false discovery rate adjusted P-values were estimated in order to minimise the effects of multiple testing and the finding of false-positive statistical associations. Table 1 shows the practice characteristics of the NHS-DPPD and CPRD practices. There were 28 million antibiotic prescriptions and 840 million other medicines recorded in NHS-DPPD. Figure 1 shows the rates of antibiotic and other prescribing in NHS-DPPD and CPRD practices (each circle representing a practice). The adjusted regression model of prescription of other medicines and other determinants explained 56% of the variation of antibiotic prescription in NHS-DPPD (62.9% in CPRD). When removing the prescribing rate of other medicines from the model, this variation reduced to 40.7%. Analysis of variance (Anova) model comparison showed that the model with the prescribing rate of other medicines was a statistically better model than the model without. Practices with higher levels of prescribing of other medicines also issued considerably more antibiotics. Pearson coefficients between prescribing of antibiotics and other medicines was 0.65 in NHS-DPPD (0.70 in CPRD), between n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a antibiotics and non-opioid analgesics 0.61 in NHS-DPPD (0.72 in CPRD), and between antibiotics and benzodiazepines 0.47 in NHS-DPPD (0.60 in CPRD). Table 2 displays the associations between prescribing of antibiotics and other medicines, benzodiazepines, and non-opioid analgesics. NHS-DPPD practices prescribed, on average, 576.1 antibiotics per 1000 patients per year. There was marked variation in the rate of antibiotic prescribing across NHS-DPPD practices, ranging from a rate of 329.9 in the 5th percentile to 808.7 in the 95th percentile. There was also strong variability in the prescribing of other medicines across practices (rate of 8815.9 in 5th and 27159.8 in 95th percentiles). As shown in Table 2 , the rate of antibiotic prescribing of highprescribing practices was 80% and, after statistical adjustment, 60% higher than lowprescribing practices. Similar results were found in CPRD practices.
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RESULTS
The prescribing of non-opioid analgesics ( Figure 2 ) and benzodiazepines ( Figure 3 ) was also strongly correlated with that of antibiotics. The adjusted regression model of prescription of painkillers and other determinants explained 53.2% (55.1% in CPRD) of the variation of antibiotic prescription in NHS-DPPD. NHS-DPPD practices with high levels of prescribing of non-opioid analgesics (95th percentile) gave 70% and, after statistical adjustment, 60% more antibiotics compared with lowprescribing practices (5th percentile). The adjusted regression model of prescription of benzodiazepines and other determinants explained 49.6% (46.4% in CPRD) of the variation of antibiotic prescription in NHS-DPPD. Benzodiazepine prescribing was also strongly related to antibiotic prescribing with, respectively, 50% and, after statistical adjustment, 30% higher antibiotic prescribing between low-and high-prescribing NHS-DPPD practices. When increasing only one risk factor from the 5th to the 95th percentile and holding all other risk factors constant, the rate of prescribing for other medicines was associated with the biggest change of antibiotic prescribing in NHS-DPPD (276.3, 95% CI = 265.4 to 287.2) compared with other risk factors, including indicators of socioeconomic status (Table 3) . Table 4 presents the result of the explorative analyses of BNF classes that had the most significant associations (those with the smallest P-values) with antibiotic prescribing. It was found that prescribing of proton pump inhibitors and that of antibiotics was significantly associated. Other significantly correlated medication classes included oral glucocorticoids and selective serotonin reuptake inhibitors. 
DISCUSSION
Summary
The authors found an association between the prescribing at practice level of antibiotics and that of other medicines, non-opioid analgesics, and benzodiazepines. The rate of prescribing of other medicines was comparatively a more important risk factor for antibiotic prescribing than any other risk factors included in this study, such as deprivation. Explorative analyses also found that prescribing of proton pump inhibitors was also correlated with antibiotic prescribing.
In conclusion, the propensity of GPs to prescribe medications generally is an important driver for antibiotic prescribing. Interventions that aim to optimise antibiotic prescribing will need to consider general prescribing behaviours of GPs.
Strengths and limitations
This study has several limitations. One limitation was that CPRD practices were also included in NHS-DPPD, but both analyses were done independently and included different risk factors. This was also an observation study without randomisation between different levels of prescribing, and some risk factors were not available, such as non-Western migrant status and sociocultural-determined expectations from patients. However, the authors did include strong risk factors of antibiotic prescribing as used in previous studies, 15 such as practice location and deprivation score. The deprivation scores in NHS-DPPD analyses were based on the postcodes of practices rather than on the postcodes of patients, which may not fully represent patients' deprivation. A further limitation was that the authors did not have information on the clinical reason for prescribing in the NHS-DPPD. Higher prescribing of, for example, antiplatelet drugs might be explained by a proactive prevention-oriented approach.
Comparison with existing literature
Wang et al evaluated predictors of antibiotic prescribing in UK general practice, and reported that characteristics of general practices associated with higher antibiotic prescribing include practice location, shorter duration of GP appointments, nontraining practices, and percentage of GPs who are male, >45 years old, and qualified outside the UK. 15 That study included only nine predictors, which explained 17.2% of the variation, 15 whereas the current model explained 56% of the variation in antibiotic prescribing. A recent Danish study showed that insufficient or overuse of diagnostic tests, lower rates of phone consultations, and higher consultation rates in the practice were associated with higher rates of antibiotic prescribing. 19 The current study confirms that practice characteristics are important predictors of the levels of antibiotic prescribing, and that these may be more important than other risk factors, such as socioeconomic status 15, 20, 21 or patient characteristics.
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Implications for research and practice Current indicators of antibiotic prescribing in general practices do not take into account practice or population characteristics. The current measure in England is STAR PU, which only takes into account the age and sex of patients in the practice to determine the number of antibiotic prescriptions. 22 In this study, regression analysis was used to compare practices, taking into account age, sex, and multiple other risk factors. The authors' results indicate the need for further adjustment for patient population in these indicators to enable fair comparison between practices, and to target interventions appropriately.
The rates of antibiotic prescribing in UK general practice have fallen in recent years, but remain high. 23 Several interventions have been implemented or tested, but the effectiveness of most of these interventions has been modest, either through limited implementation or limited effect size. Most of the interventions have focused directly on antibiotic prescribing or the understanding of infections. Education of clinicians and/or patients has been found to improve antibiotic prescribing. 24 One of the most widely used interventions has been public awareness campaigns of antibiotics and infections. 25 Studies have shown that the public often misunderstand the differences between bacterial and viral infections. 26 The evidence for long-term effectiveness of public campaigns is limited. 27 A cluster trial of a behavioural intervention reported a shortterm reduction in antibiotic prescribing in high-prescribing practices after receiving a letter from the Chief Medical Officer in December 2014. 7 However, it is unclear whether these effects were sustained over time. A UK-based cluster trial of a remotely installed, computer-delivered decision support tool that could be accessed during the consultation found a small effect on the rate of antibiotic prescribing. 28 The current study confirms the conclusion from another study that a whole-system approach is needed to understand the factors influencing antibiotic management to improve the appropriate use of antibiotics in primary care. 29 One whole-systematic approach could involve pharmacists integrated with a practice. A recent programme in England involves pharmacists who review medication expenditure, 30 hazardous prescribing to individual patients, 31 and transfer of prescribing for patients referred from secondary care. 32 This approach may be extended to also review the overall prescribing behaviour of practices compared with similar practices, in order to optimise the quality of prescribing in practices. Of course, the effectiveness and impact of these interventions will need to be evaluated.
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